The European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2016: a summary

Anneke Kramer*, Maria Pippias, Marlies Noordzij, Vianda S Stel, Anton M Andrusev, Manuel I Aparicio-Madre, Federico E Arribas Monzón, Anders Åsberg, Myftar Barbullushi, Palma Beltrán, Marjolein Bonthuis, Fergus J Caskey, Pablo Castro de la Nuez, Harijs Cernevskis, Johan De Meester, Patrik Finne, Eliezer Golan, James G Heaf, Marc H Hemmelder, Kyriakos IoannouNino Kantaria, Kirill Komissarov, Grzegorz Korejwo, Reinhard Kramar, Mathilde Lassalle, František Lopot, Fernando Macário, Bruce Mackinnon, Runólfur Pálsson, Ülle Pechter, Vicente C Piñera, Carmen Santiuste de Pablos, Alfons Segarra-Medrano, Nurhan Seyahi, Maria F Slon Roblero, Olivera Stojceva-Taneva, Evgueniy Vazelov, Rebecca Winzeler, Edita Ziginskiene, Ziad Massy, Kitty J Jager

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskriftArtikelForskningpeer review

Abstract

Background: This article summarizes the ERA-EDTA Registry's 2016 Annual Report, by describing the epidemiology of renal replacement therapy (RRT) for end-stage renal disease (ESRD) in 2016 within 36 countries.

Methods: In 2017 and 2018, the ERA-EDTA Registry received data on patients undergoing RRT for ESRD in 2016 from 52 national or regional renal registries. In all, 32 registries provided individual patient data and 20 provided aggregated data. The incidence and prevalence of RRT and the survival probabilities of these patients were determined.

Results: In 2016, the incidence of RRT for ESRD was 121 per million population (pmp), ranging from 29 pmp in Ukraine to 251 pmp in Greece. Almost two-thirds of patients were men, over half were aged ?65?years and almost a quarter had diabetes mellitus as their primary renal diagnosis. Treatment modality at the start of RRT was haemodialysis for 84% of patients. On 31 December 2016, the prevalence of RRT was 823 pmp, ranging from 188 pmp in Ukraine to 1906 pmp in Portugal. In 2016, the transplant rate was 32 pmp, varying from 3 pmp in Ukraine to 94 pmp in the Spanish region of Catalonia. For patients commencing RRT during 2007-11, the 5-year unadjusted patient survival probability on all RRT modalities combined was 50.5%. For 2016, the incidence and prevalence of RRT were higher among men (187 and 1381 pmp) than women (101 and 827 pmp), and men had a higher rate of kidney transplantation (59 pmp) compared with women (33 pmp). For patients starting dialysis and for patients receiving a kidney transplant during 2007-11, the adjusted patient survival probabilities appeared to be higher for women than for men.

OriginalsprogEngelsk
Sider (fra-til)702-720
Antal sider19
TidsskriftCKJ: Clinical Kidney Journal
Vol/bind12
Udgave nummer5
DOI
StatusUdgivet - 2019

Bibliografisk note

� The Author(s) 2019. Published by Oxford University Press on behalf of ERA-EDTA.

Fingeraftryk

Udforsk hvilke forskningsemner 'The European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2016: a summary' indeholder.

Citationsformater